文献速递细菌感染、耐药与抗菌药物医院感染防控

养老院与社区老年人群尿路感染肠杆菌耐药性比较

Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

该回顾性观察研究分析2014至2017年法国东北部约2万份65岁以上人群尿液阳性样本,采用多因素logistic回归校正患者特征,比较养老院居民与社区居住者肠杆菌对多种抗生素的耐药性。结果显示养老院居民对阿莫西林/克拉维酸、环丙沙星、头孢曲松耐药及产ESBL的调整OR均显著升高,而对呋喃妥因和复方磺胺甲噁唑耐药无差异。

要点

  • 养老院老年居民尿培养肠杆菌耐药风险较社区同龄人高约40%。
  • 阿莫西林/克拉维酸、环丙沙星、头孢曲松耐药及产ESBL风险显著升高。
  • 呋喃妥因和复方磺胺甲噁唑耐药在两组间无差异。

核心结论

  • 养老院老年居民尿液样本中耐药肠杆菌的检出风险约为社区居住同龄人的1.4倍。
  • 建议在养老院实施抗菌药物管理和感染预防控制规划。

研究设计与样本

  • 采用多因素logistic回归模型校正性别、年龄、采样年份、留置导尿管及每年尿液样本数。

主要发现

  • 养老院居民肠杆菌对阿莫西林/克拉维酸耐药的aOR为1.38(95%CI 1.27-1.50)。
  • 养老院居民肠杆菌对环丙沙星耐药的aOR为1.33(95%CI 1.20-1.49)。
  • 养老院居民肠杆菌对头孢曲松耐药的aOR为1.37(95%CI 1.15-1.63)。
  • 养老院居民肠杆菌产ESBL的aOR为1.43(95%CI 1.18-1.72)。
  • 两组对呋喃妥因和复方磺胺甲噁唑耐药无差异。

关键数值与推荐

  • 比较的菌种包括大肠埃希菌、奇异变形杆菌和肺炎克雷伯菌。
  • 比较的抗生素包括阿莫西林/克拉维酸、呋喃妥因、复方磺胺甲噁唑、萘啶酸、氧氟沙星、环丙沙星和头孢曲松,以及ESBL产生。

临床怎么用

  • 对养老院老年患者尿路感染经验性用药时,应考虑到耐药肠杆菌风险较社区居住者高约40%。
  • 呋喃妥因和复方磺胺甲噁唑耐药在两组间无差异,可作为参考选项。
  • 应在养老院推行抗菌药物管理及感染预防控制措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Although nursing homes are thought to be significant reservoirs of antibiotic-resistant bacteria, very few large population-based studies comparing antibiotic resistance prevalence in nursing homes and in the community have adjusted for patient characteristics. Our objective was to compare the prevalence of antibiotic resistance of Enterobacteriaceae cultured from urine samples of nursing home residents with that of community-dwelling adults, all aged 65 years or older. METHODS: This study analysed around 20 000 positive urine samples sent to a large laboratory in north-eastern France from 2014 to 2017, collected from individuals aged 65 years or older. A multivariable logistic regression model adjusted for patient characteristics (gender, age, year of sampling, presence of urinary catheter and number of urine samples/year) compared the resistance of Escherichia coli, Proteus mirabilis and Klebsiella pneumoniae to amoxicillin/clavulanate, nitrofurantoin, trimethoprim/sulfamethoxazole, nalidixic acid, ofloxacin, ciprofloxacin and ceftriaxone, as well as their possible EBSL production, in nursing home residents and community-dwellers. RESULTS: Nursing home residents had a higher adjusted OR (aOR) of Enterobacteriaceae (E. coli, P. mirabilis or K. pneumoniae) resistant to amoxicillin/clavulanate (aOR 1.38, 95% CI 1.27-1.50), ciprofloxacin (aOR 1.33, 95% CI 1.20-1.49) and ceftriaxone (aOR 1.37, 95% CI 1.15-1.63) or producing an ESBL (aOR 1.43, 95% CI 1.18-1.72), but did not differ in resistance to nitrofurantoin or trimethoprim/sulfamethoxazole. CONCLUSIONS: Elderly people in nursing homes had a risk around 40% higher than their community-dwelling peers of having antibiotic-resistant Enterobacteriaceae cultured from their urine samples. Antibiotic stewardship and infection prevention and control programmes should be implemented in nursing homes.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Pulcini C, Clerc-Urmes I, Attinsounon CA, et al. Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study. J Antimicrob Chemother. 2019. PMID: 30508107. doi:10.1093/jac/dky488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。